{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:58:25Z","timestamp":1781643505727,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lichens produce several secondary metabolites with significant biological and pharmacological activities, among which usnic acid (UA) is particularly notable. This study aimed to investigate the cytotoxic activity, effects on cell migration and invasion, and the mechanisms underlying UA-induced cell death in the human hepatocarcinoma cell line Hep3B.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Hep3B cells were treated with UA for 24 and 48\u00a0h to evaluate its cytotoxicity. Gene expression levels associated with apoptosis and cell migration were analyzed. Functional assays, including scratch-wound and Matrigel invasion assays, were employed to assess migration and invasion. Additionally, molecular docking studies were conducted to elucidate the interactions between UA and potential protein targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      UA demonstrated significant cytotoxic effects on Hep3B cells, with an IC\n                      <jats:sub>50<\/jats:sub>\n                      of 19.677\u00a0\u00b5M at 48\u00a0h. UA treatment induced apoptosis and effectively suppressed cell migration and invasion. Molecular docking analyses revealed strong binding interactions between UA and key target proteins, as evidenced by negative binding energy values for all complexes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate that UA exerts cytotoxic effects on Hep3B cells by inducing apoptosis and inhibiting migration and invasion. The molecular docking results further suggest UA as a potential lead compound for anticancer drug development. Further investigations focusing on its molecular targets and derivatives are warranted to explore its full therapeutic potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-026-05354-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:33:20Z","timestamp":1774251200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Usnic acid induces apoptosis and inhibits cell migration and invasion in hepatocarcinoma cells: in vitro and in silico analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3259-5822","authenticated-orcid":false,"given":"Dogukan","family":"Mutlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"5354_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"5354_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt S-M. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21:162\u201380.","journal-title":"Nat Rev Cancer"},{"key":"5354_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","volume":"22","author":"F Weiss","year":"2022","unstructured":"Weiss F, Lauffenburger D, Friedl P. Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. Nat Rev Cancer. 2022;22:157\u201373.","journal-title":"Nat Rev Cancer"},{"key":"5354_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu J-J, Ding J. Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect. 2021;11:5\u201313.","journal-title":"Nat Prod Bioprospect"},{"key":"5354_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primer. 2021;7:6.","journal-title":"Nat Rev Dis Primer"},{"key":"5354_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","volume":"5","author":"J Bruix","year":"2004","unstructured":"Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5:215\u20139.","journal-title":"Cancer Cell"},{"key":"5354_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.phrs.2009.01.017","volume":"59","author":"S Nobili","year":"2009","unstructured":"Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res. 2009;59:365\u201378.","journal-title":"Pharmacol Res"},{"key":"5354_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s002530100684","volume":"56","author":"K M\u00fcller","year":"2001","unstructured":"M\u00fcller K. Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol. 2001;56:9\u201316.","journal-title":"Appl Microbiol Biotechnol"},{"key":"5354_CR9","doi-asserted-by":"crossref","unstructured":"Rankovi\u0107 B, Kosani\u0107 M. Lichens as a potential source of bioactive secondary metabolites. In: Rankovi\u0107 B, editor. Lichen Second Metab. Cham: Springer International Publishing; 2019. pp. 1-29. Available from: http:\/\/link.springer.com\/10.1007\/978-3-030-16814-8_1. Cited 2024 Oct 10.","DOI":"10.1007\/978-3-030-16814-8_1"},{"key":"5354_CR10","doi-asserted-by":"publisher","first-page":"R502","DOI":"10.1016\/j.cub.2009.04.034","volume":"19","author":"F Lutzoni","year":"2009","unstructured":"Lutzoni F, Miadlikowska J. Lichens. Curr Biol. 2009;19:R502\u20133.","journal-title":"Curr Biol"},{"key":"5354_CR11","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1128\/AAC.39.11.2541","volume":"39","author":"M Lauterwein","year":"1995","unstructured":"Lauterwein M, Oethinger M, Belsner K, Peters T, Marre R. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother. 1995;39:2541\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"5354_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0031-9422(02)00383-7","volume":"61","author":"K Ing\u00f3lfsd\u00f3ttir","year":"2002","unstructured":"Ing\u00f3lfsd\u00f3ttir K. Usnic acid. Phytochemistry. 2002;61:729\u201336.","journal-title":"Phytochemistry"},{"key":"5354_CR13","doi-asserted-by":"crossref","unstructured":"Vartia KO. Antibiotics in lichens. The Lichens. Elsevier; 1973. pp. 547-61. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780120449507500222. Cited 2024 Oct 10.","DOI":"10.1016\/B978-0-12-044950-7.50022-2"},{"key":"5354_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00114-002-0305-3","volume":"89","author":"M Cocchietto","year":"2002","unstructured":"Cocchietto M, Skert N, Nimis P, Sava G. A review on usnic acid, an interesting natural compound. Naturwissenschaften. 2002;89:137\u201346.","journal-title":"Naturwissenschaften"},{"key":"5354_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.29233\/sdufeffd.1250542","volume":"18","author":"D Mutlu","year":"2023","unstructured":"Mutlu D, Se\u00e7me M, Arslan \u015e. Effects of Usnic Acid on Cytotoxicity, Colony Formation and Migration in SK-UT-1 Human Uterine Leiomyosarcoma Cells. S\u00fcleyman Demirel \u00dcniversitesi Fen Edeb Fak\u00fcltesi Fen Derg. 2023;18:195\u2013202.","journal-title":"S\u00fcleyman Demirel \u00dcniversitesi Fen Edeb Fak\u00fcltesi Fen Derg"},{"key":"5354_CR16","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.toxrep.2019.11.003","volume":"6","author":"K Cetin Cakmak","year":"2019","unstructured":"Cetin Cakmak K, G\u00fcl\u00e7in \u0130. Anticholinergic and antioxidant activities of usnic acid-an activity-structure insight. Toxicol Rep. 2019;6:1273\u201380.","journal-title":"Toxicol Rep"},{"key":"5354_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/ph14090945","volume":"14","author":"A Galanty","year":"2021","unstructured":"Galanty A, Zagrodzki P, Gdula-Argasi\u0144ska J, Grabowska K, Koczurkiewicz-Adamczyk P, Wr\u00f3bel-Biedrawa D, et al. A Comparative survey of anti-melanoma and anti-inflammatory potential of usnic acid enantiomers\u2014a comprehensive in vitro approach. Pharmaceuticals. 2021;14:945.","journal-title":"Pharmaceuticals"},{"key":"5354_CR18","doi-asserted-by":"publisher","first-page":"e0146575","DOI":"10.1371\/journal.pone.0146575","volume":"11","author":"Y Yang","year":"2016","unstructured":"Yang Y, Nguyen TT, Jeong M-H, Cri\u015fan F, Yu YH, Ha HH, et al. Inhibitory activity of (+)-usnic acid against non-small cell lung cancer cell motility. PLOS one. 2016;11:e0146575 Andr\u00e9 F, editor.","journal-title":"PLOS one."},{"key":"5354_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.12659\/MSM.908568","volume":"24","author":"X Geng","year":"2018","unstructured":"Geng X, Zhang X, Zhou B, Zhang C, Tu J, Chen X, et al. Usnic acid induces cycle arrest, apoptosis, and autophagy in gastric cancer cells in vitro and in vivo. Med Sci Monit. 2018;24:556\u201366.","journal-title":"Med Sci Monit"},{"key":"5354_CR20","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/ijms23031802","volume":"23","author":"A Pyrczak-Felczykowska","year":"2022","unstructured":"Pyrczak-Felczykowska A, Reekie TA, J\u0105kalski M, Ha\u0107 A, Malinowska M, Pawlik A, et al. The isoxazole derivative of usnic acid induces an ER stress response in breast cancer cells that leads to paraptosis-like cell death. Int J Mol Sci. 2022;23:1802.","journal-title":"Int J Mol Sci"},{"key":"5354_CR21","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1021\/jacsau.3c00774","volume":"4","author":"M Varl\u0131","year":"2024","unstructured":"Varl\u0131 M, Bhosle SR, Kim E, Yang Y, Ta\u015f \u0130, Zhou R, et al. Usnic acid targets 14-3-3 proteins and suppresses cancer progression by blocking substrate interaction. JACS Au. 2024;4:1521\u201337.","journal-title":"JACS Au"},{"key":"5354_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/plants12030519","volume":"12","author":"M Kumari","year":"2023","unstructured":"Kumari M, Kamat S, Singh SK, Kumar A, Jayabaskaran C. Inhibition of autophagy increases cell death in HeLa cells through usnic acid isolated from lichens. Plants. 2023;12:519.","journal-title":"Plants"},{"key":"5354_CR23","doi-asserted-by":"publisher","first-page":"105791","DOI":"10.1016\/j.mtcomm.2023.105791","volume":"35","author":"K \u015earkaya","year":"2023","unstructured":"\u015earkaya K, \u00c7ad\u0131rc\u0131 M, \u00c7etin K, Mutlu D, Arslan \u015e. PHEMA\/PPy cytocompatible conductive cryogels: One-pot synthesis, characterization, and electrical properties. Mater Today Commun. 2023;35:105791.","journal-title":"Mater Today Commun"},{"key":"5354_CR24","doi-asserted-by":"publisher","unstructured":"Arslan \u015e, Kocabiyik K, Mutlu D, Semiz G. Assessment of cytotoxic and apoptotic effects of salvia syriaca L. in colorectal adenocarcinoma Cell Line (Caco-2). Iran J Pharm Res. 2021;20. Available from: https:\/\/doi.org\/10.22037\/ijpr.2020.114254.14759. Cited 2024 Oct 10.","DOI":"10.22037\/ijpr.2020.114254.14759"},{"key":"5354_CR25","doi-asserted-by":"publisher","first-page":"133482","DOI":"10.1016\/j.molstruc.2022.133482","volume":"1265","author":"R Liman","year":"2022","unstructured":"Liman R, Kursunlu AN, Ozmen M, Arslan S, Mutlu D, Istifli ES, et al. Synthesis of water soluble symmetric and asymmetric pillar[5]arene derivatives: cytotoxicity, apoptosis and molecular docking studies. J Mol Struct. 2022;1265:133482.","journal-title":"J Mol Struct"},{"key":"5354_CR26","doi-asserted-by":"publisher","first-page":"e202300878","DOI":"10.1002\/cbdv.202300878","volume":"20","author":"NNB Kart","year":"2023","unstructured":"Kart NNB, G\u00fcnal B, Mutlu D, Do\u011fan NM, Arslan \u015e, Semiz G. Evaluating antibiofilm, cytotoxic and apoptotic activities of Scutellaria brevibracteata subsp. brevibracteata essential oil. Chem Biodivers. 2023;20:e202300878.","journal-title":"Chem Biodivers"},{"key":"5354_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.sajb.2023.03.046","volume":"157","author":"M Secme","year":"2023","unstructured":"Secme M, Mutlu D, Elmas L, Arslan S. Assessing effects of caffeic acid on cytotoxicity, apoptosis, invasion, GST enzyme activity, oxidant, antioxidant status and micro-RNA expressions in HCT116 colorectal cancer cells. South Afr J Bot. 2023;157:19\u201326.","journal-title":"South Afr J Bot"},{"key":"5354_CR28","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2024;52:W513\u201320.","journal-title":"Nucleic Acids Res"},{"key":"5354_CR29","doi-asserted-by":"publisher","first-page":"716466","DOI":"10.3389\/fmolb.2021.716466","volume":"8","author":"S Murail","year":"2021","unstructured":"Murail S, De Vries SJ, Rey J, Moroy G, Tuff\u00e9ry P. SeamDock: an interactive and collaborative online docking resource to assist small compound molecular docking. Front Mol Biosci. 2021;8:716466.","journal-title":"Front Mol Biosci"},{"key":"5354_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/0960327118792052","volume":"38","author":"B Yurdacan","year":"2019","unstructured":"Yurdacan B, Egeli U, Eskiler GG, Eryilmaz I, Cecener G, Tunca B. The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma. Hum Exp Toxicol. 2019;38:201\u201315.","journal-title":"Hum Exp Toxicol"},{"key":"5354_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1039\/C4RA12340A","volume":"5","author":"S Zuo","year":"2015","unstructured":"Zuo S, Wang L, Zhang Y, Zhao D, Li Q, Shao D, et al. Usnic acid induces apoptosis via an ROS-dependent mitochondrial pathway in human breast cancer cells in vitro and in vivo. RSC Adv. 2015;5:153\u201362.","journal-title":"RSC Adv"},{"key":"5354_CR32","first-page":"0","volume":"0","author":"\u00d6 Erdo\u011fan","year":"2023","unstructured":"Erdo\u011fan \u00d6, Abas B, \u00c7evik \u00d6. Usnic acid exerts antiproliferative and apoptotic effects by suppressing NF-B p50 in DU145 cells. Eur J Biol. 2023;0:0\u20130.","journal-title":"Eur J Biol"},{"key":"5354_CR33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1021\/acs.jnatprod.6b00917","volume":"80","author":"HY Ebrahim","year":"2017","unstructured":"Ebrahim HY, Akl MR, Elsayed HE, Hill RA, El Sayed KA. Usnic acid benzylidene analogues as potent mechanistic target of rapamycin inhibitors for the control of breast malignancies. J Nat Prod. 2017;80:932\u201352.","journal-title":"J Nat Prod"},{"key":"5354_CR34","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1002\/ptr.7103","volume":"35","author":"TX Sun","year":"2021","unstructured":"Sun TX, Li MY, Zhang ZH, Wang JY, Xing Y, Ri M, et al. Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD-L1 expression and enhancing T-lymphocyte tumor-killing activity. Phytother Res. 2021;35:3916\u201335.","journal-title":"Phytother Res"},{"key":"5354_CR35","doi-asserted-by":"publisher","first-page":"16234","DOI":"10.1038\/s41598-018-34709-9","volume":"8","author":"Y Yang","year":"2018","unstructured":"Yang Y, Bae WK, Lee J-Y, Choi YJ, Lee KH, Park M-S, et al. Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. Sci Rep. 2018;8:16234.","journal-title":"Sci Rep"},{"issue":"3","key":"5354_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10456-012-9270-4","volume":"15","author":"Y Song","year":"2012","unstructured":"Song Y, Dai F, Zhai D, Dong Y, Zhang J, Lu B, et al. Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1\/2 signaling pathways. Angiogenesis. 2012;15(3):421\u201332.","journal-title":"Angiogenesis"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05354-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:41:11Z","timestamp":1781642471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05354-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5354"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05354-x","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}